GP-Act III Acquisition EBIT

As of the most recent data (June 2026), GPAT shows a EBIT of $-2.2M. That compares with $-670K in the prior-year period — down 235.3% year over year. That is below the sector sector average of $2.6T. Scroll down for historical charts and peer comparison views.

Compared with the year-ago period, GPAT's EBIT is now $-2.2M (was $-670K) — a 235.3% year-over-year decrease. Pairing that YoY change with peer averages gives a clearer picture of whether GP-Act III Acquisition is outperforming or lagging.

The its sector sector average EBIT is about $2.6T. GP-Act III Acquisition is at $-2.2M, which is lower that average. That is roughly 100.0% below the sector mean. Use the comparison chart on this page to see how GPAT stacks up against individual peers as well.

Tracking GPAT's ebit over time shows whether GP-Act III Acquisition is scaling, shrinking, or reshaping that part of the business. The current reading is $-2.2M That compares with $-670K in the prior-year period — down 235.3% year over year. Multi-quarter patterns matter more than any single print, which is why this page emphasizes history and peer comparison charts.

Besides this ebit page, Stockcircle has GP-Act III Acquisition's full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect EBIT (currently $-2.2M) with ownership activity and broader fundamentals.